Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir for Generalized Periodontitis
NCT05902208Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Feb 2024
- Primary completion
- May 2026
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in periodontitis comparing Valaciclovir with Placebo (2 arms). Primary endpoint: Efficacy of antiviral treatment compared to placebo. Started Feb 2024; status: recruiting.
02
Drugs
valaciclovir
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT05902208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05902208.